Abstract:Objective To evaluate the predictive values of indocyanine green retention rate at 15 min (ICGR15), model for end-stage liver disease (MELD) score and prothrombin time (PT) on short-term prognosis in patients with liver failure, and study the role of artificial liver support system (ALSS) on liver failure disease. Methods ICGR15, MELD scores and PT were detected in 83 cases with liver failure before the therapy of plasma exchange. The areas under curve (AUC) of the ICGR15, MELD scores and PT were calulated and compared. The patients were divided into effective group (54 cases, cured or improved) and ineffective group (29 cases, died or uncured) according to clinical outcomes. Results Nine and 5 cases were cured in early and middle period of subacute liver failure (SALF) respectively, and no significant difference was found (P>0.05). Fifteen and 24 cases were improved in early and middle periods of subacute-on-chronic liver failure (ACLF), respectively. The improvement condition in early period of ACLF was better than the middle period (P<0.05). There is no significant difference between the SALF group and ACLF group in the early and middle period (P>0.05). The ICGR15, MELD scores and PT in effective group and ineffective group were (48.333±11.482)% vs (54.817±6.514)%(t=3.281, P<0.050), (28.11±4.19) vs (33.52±4.09)(t=5.655,P<0.05) and (26.028±6.690) s vs (38.300±13.405) s (t=4.63,P<0.05), respectively. The AUC of ICGR15, MELD scores and PT for the short-term prediction of prognosis was 0.712(95%CI 0.602～0.822), 0.852(95%CI 0.765～0.939) and 0.801(95%CI 0.695～0.906). There were no significant difference among them (all P>0.05). Conclusions The curative effect is closely related with the treatment time. The higher ICGR15, MELD scores and PT indicate the severer disease condition. ICGR15, MELD scoring system and PT can predict the short-term prognosis of liver failure.

Assessment of Resin Perfusion in Hepatic Failurein Vitroandin Vivo

Effect of hemoperfusion with adsorbents containing ser ligand for endotoxin removal on lung injuries in a porcine model of endotoxemia

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

Effects of Plasma from Acute-on-chronic Liver Failure Patients on Immortalized Human Hepatocytes in Vitro.

Efficacy of A Novel Endotoxin Adsorber Polyvinylidene Fluoride Fiber Immobilized with L-Serine Ligand on Septic Pigs

Study on Experiment in Vitro of Polyvinylidene Fluoride Fiber Used for Endotoxin Adsorption

Effects of Plasma from Patients with Acute on Chronic Liver Failure on Function of Cytochrome P450 in Immortalized Human Hepatocytes.

Predictive values of three indexes on short-term prognosis in patients with liver failure treated by artificial liver support system

Amino-rich Nanofiber Membrane with Favorable Hemocompatibility for Highly Efficient Removal of Bilirubin from Plasma

Assessment of the Combined Effect of Plasma Exchange and Plasma Perfusion on Patients with Severe Hepatitis Awaiting Orthotopic Liver Transplantation

Effects of Hemoperfusion Adsorption And/or Plasma Exchange in Treatment of Severe Viral Hepatitis: A Comparative Study

Efficacy of Coupled Low-Volume Plasma Exchange with Plasma Filtration Adsorption in Treating Pigs with Acute Liver Failure: A Randomised Study.

Comparitive study of middle and mixed artificial livers in treatment of hepatic failure

Plasma Exchange-Centered Artificial Liver Support System in Hepatitis B Virus-Related Acute-on-chronic Liver Failure: a Nationwide Prospective Multicenter Study in China.

Extra-corporeal non-liver transplant therapies for acute liver failure: Focus on plasma exchange and continuous renal replacement therapy

Biochemical assessment and clinical evaluation of a non-ionic adsorbent resin in patients with intractable jaundice

Changes of serum cytokine levels in patients with acute on chronic liver failure treated by plasma exchange.

Evaluation of Hydromechanical and Functional Properties of Diversion-Type Microcapsule-Suspension Bioreactor for Bioartificial Liver

[New apparatus for artificial liver support: PAT resin--removal of protein-bound substances and its effect on hepatic failure in animals]

Efficacy of Fluidized Bed Bioartificial Liver in Treating Fulminant Hepatic Failure in Pigs: A Metabolomics Study

[Clinical Research of Plasma Exchange with Continuous Veno-Venous Hemofiltration in Treating Mid- and Late-Stage Chronic Severe Viral Hepatitis B Patients].